Remission as perceived by people with schizophrenia, family members and psychiatrists

European Psychiatry : the Journal of the Association of European Psychiatrists
Anne KarowEGOFORS Initiative

Abstract

Studies indicate that patient-rated outcomes and symptomatic remission as defined by the remission in schizophrenia working group rely on different assumptions. The aim of this observational study was to assess symptomatic remission by patients with schizophrenia, family members and psychiatrists and to compare their assessments with standardized criteria and clinical measures. One hundred and thirty-one patients with schizophrenia (DSM-IV), family members and psychiatrists assessed remission within the European Group on Functional Outcomes and Remission in Schizophrenia (EGOFORS) project. Symptoms (Positive and Negative Syndrome Scale [PANSS]), functional outcome (Functional Recovery Scale in Schizophrenia [FROGS]), subjective well-being (SWN-K) and demographic characteristics were investigated. Remission assessed by psychiatrists showed the best accordance with standardized remission (80%), followed by remission assessed by family members (52%) and patients (43%). Only in 18%, patients, relatives and psychiatrists agreed in their assessments. Good subjective well-being was most important for remission estimated by patients, good subjective well-being and symptom reduction by family members, and finally better symptom scores, ...Continue Reading

References

Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Aug 24, 2001·Schizophrenia Research·J D HuppertT E Smith
Jun 24, 2003·The Journal of Nervous and Mental Disease·Michael Ritsner
Jul 4, 2003·Archives of Psychiatric Nursing·Johannes JungbauerMatthias C Angermeyer
Aug 25, 2004·Journal of Advanced Nursing·Johannes JungbauerMatthias C Angermeyer
Oct 27, 2004·European Psychiatry : the Journal of the Association of European Psychiatrists·M LambertD Naber
Jan 6, 2005·Schizophrenia Bulletin·Johannes JungbauerMatthias C Angermeyer
Mar 3, 2005·The American Journal of Psychiatry·Nancy C AndreasenDaniel R Weinberger
Jul 5, 2005·European Archives of Psychiatry and Clinical Neuroscience·Max BirchwoodRachel Upthegrove
Sep 21, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·Alex HoferW Wolfgang Fleischhacker
Oct 15, 2005·Psychopathology·A KarowM Krausz
Jan 21, 2006·Acta Psychiatrica Scandinavica·Nancy C Andreasen
Jan 21, 2006·Acta Psychiatrica Scandinavica·J van OsJ M Kane
Mar 1, 2007·Pharmacopsychiatry·A HoferW W Fleischhacker
Apr 3, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Christiane RoickUNKNOWN EuroSC Research Group
Jan 18, 2008·PharmacoEconomics·A George Awad, Lakshmi N P Voruganti
May 21, 2008·The International Journal of Social Psychiatry·Roger M K NgEric Y H Chen
Mar 27, 2009·Schizophrenia Research·Martin LambertBenno G Schimmelmann
May 8, 2009·The International Journal of Neuropsychopharmacology·Steven G PotkinCynthia O Siu

❮ Previous
Next ❯

Citations

Apr 21, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Sung-Wan KimYoung-Myo Jae
Feb 6, 2014·Psychiatry Research·Kristin KlapheckThomas Bock
Sep 28, 2014·European Archives of Psychiatry and Clinical Neuroscience·Rebecca SchennachHans-Jürgen Möller
Jul 7, 2016·European Archives of Psychiatry and Clinical Neuroscience·Alessandro RossiUNKNOWN Italian Network for Research on Psychoses
Nov 16, 2012·Schizophrenia Research·Wing Chung ChangEric Yu Hai Chen
Feb 11, 2015·The Journal of Nervous and Mental Disease·Gagan FervahaGary Remington
Apr 23, 2013·Expert Opinion on Therapeutic Targets·Mari TakaloMikko Hiltunen
Apr 21, 2017·Health and Quality of Life Outcomes·Alejandra Caqueo-UrízarDavid R Williams
Jan 21, 2018·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Paul H LysakerJenifer L Vohs
Oct 19, 2017·Psychiatry Investigation·Sung-Wan KimJin-Sang Yoon
Sep 9, 2017·Expert Review of Neurotherapeutics·Bethany L LeonhardtPaul H Lysaker
Jul 25, 2017·BMC Psychiatry·Joanne LloydMichele Peters

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here